- New technological platform – First of its kind in WBC / SEE
- Sustainable Microarray facility on pay-for-use basis for production of affordable DNA and protein microarrays
- Microarray prototypes
- Increased knowledge and know-how, and improved human potential
- Increased visibility at European and international level
- Improved clinical screening program for detection of new cases of AHCY deficiency based on new technology
- Maintenance of leading position in human AHCY deficiency research worldwide
Most Visited
Top stories
Restructuring Institute Rudjer Boskovic
A group of Rudjer Boskovic Institutes' (RBI) scientists has proposed a programme under the title RBI-BAR for restructuring the Molecular Medicine Department within RBI. Ruđer Bošković Institute for Biomedical and Applied Research (RBI-BAR) has set the goal to steer biomedical research into new avenues of innovation and technology, and to become the leading institute for basic and applied research in Biomedicine in Croatia and South Eastern Europe. The mission is "to provide innovative molecular solutions for major diseases of the world through scholarship and collaboration". RBI-BAR will promote the innovative use of genetic and genomic approaches and technologies for basic science discoveries and clinical research applications for the prevention, diagnosis, and treatment of relevant human diseases with focus on cancer.
IPR News
